BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20930383)

  • 1. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
    Cui X; Inagaki Y; Xu H; Wang D; Qi F; Kokudo N; Fang D; Tang W
    Biol Pharm Bull; 2010; 33(10):1728-32. PubMed ID: 20930383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The supercritical CO₂ extract from the skin of Bufo bufo gargarizans Cantor blocks hepatitis B virus antigen secretion in HepG2.2.15 cells.
    Cui X; Inagaki Y; Wang D; Gao J; Qi F; Gao B; Kokudo N; Fang D; Tang W
    Biosci Trends; 2014 Feb; 8(1):38-44. PubMed ID: 24647111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
    Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
    Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis B virus activity of chickweed [Stellaria media (L.) Vill.] extracts in HepG2.2.15 cells.
    Ma L; Song J; Shi Y; Wang C; Chen B; Xie D; Jia X
    Molecules; 2012 Jul; 17(7):8633-46. PubMed ID: 22810196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on mechanism of Chinese Yam polysaccharide synergizing nucleoside analogues against hepatitis B virus through p38 MAPK signaling pathway].
    Li CY; Wu ZH; Zheng Y; Li B; Zhang JC; Lu LX; Xie XQ; He YJ; Yu XH
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2776-2782. PubMed ID: 38812178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
    Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
    Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
    Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
    World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
    Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
    J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
    Rokuhara A; Tanaka E; Matsumoto A; Kimura T; Yamaura T; Orii K; Sun X; Yagi S; Maki N; Kiyosawa K
    J Viral Hepat; 2003 Jul; 10(4):324-30. PubMed ID: 12823601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
    Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
    Tanaka E; Matsumoto A; Yoshizawa K; Maki N
    Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
    Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
    J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis B virus
    Ge FL; Yang Y; Si LL; Li YH; Cao MZ; Wang J; Bai ZF; Ren ZG; Xiao XH; Liu Y
    World J Gastroenterol; 2024 Apr; 30(13):1911-1925. PubMed ID: 38659485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
    Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.